Hikma Pharmaceuticals Profile

USD 2.5  10.16%
24.6Last Month High 29.55 
27.1Trading Day  High 27.1 

Hikma Pharmaceuticals Summary

Hikma Pharmaceuticals PLC (HKMPY) is traded on OTC Market in USA. It is located in London, WS HW and employs 7,189 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 2.55 B. Hikma Pharmaceuticals PLC has 0 outstanding shares. HIKMA PHARM has accumulated about 265 M in cash with 419 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.21.
Check Hikma Pharmaceuticals Probability Of Bankruptcy

Hikma Pharmaceuticals PLC Risk Profiles

Key Fundamentals

Hikma Pharmaceuticals Against Markets

Current Ratings  

Hikma Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
< 41% 
Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of branded and nonbranded generic and inlicensed pharmaceutical solutions in solid, semisolid, liquid, and injectable final dosage forms in the Middle East and North Africa, the United States, Europe, the United Kingdom, and internationally. more
NameHikma Pharmaceuticals PLC
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business AddressLondon, WS HW
ExchangeOTC Market
CIK Number01470628.0
Contact Number44 20 7399 2760
CurrencyUSD - US Dollar


Hikma Pharmaceuticals Corporate Directors
Pamela Kirby Non-Executive Independent Director, Ph.D
John Castellani Non-Executive Independent Director
Ali AlHusry Non-Executive Director, MBA


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas